ChromaDex to Join Russell 2000 IndexChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced its inclusion in the Russell 2000 Index as part...
Business Wire•25 days ago